Your session is about to expire
← Back to Search
Behavioral Intervention
Pelvic floor muscle training for Urinary Incontinence
N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial aims to investigate the effectiveness of pelvic floor muscle (PFM) training in treating urinary incontinence in women with Myotonic dystrophy type 1 (DM1). The study will
Who is the study for?
This trial is for women with Myotonic Dystrophy type 1 (DM1) who experience urinary incontinence. Participants should have a confirmed diagnosis of DM1 and be dealing with issues related to pelvic floor muscle weakness.Check my eligibility
What is being tested?
The study tests the effectiveness of a 12-week Pelvic Floor Muscle Training program, which includes weekly sessions with a physiotherapist and exercises at home, on reducing urinary incontinence in women with DM1.See study design
What are the potential side effects?
While not explicitly mentioned, pelvic floor training generally has minimal side effects but may include temporary soreness or fatigue from the exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through treatment completion (session 1 to 12; 12 weeks of treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through treatment completion (session 1 to 12; 12 weeks of treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention Acceptability Questionnaire
Percentage of attended treatment sessions
Percentage of home exercises performed
+2 moreSecondary outcome measures
Change in pelvic floor disorder symptoms
Change in pelvic floor disorder symptoms related impact on quality of life
Change in pelvic floor muscles function
+6 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Pelvic floor muscle trainingExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pelvic floor muscle training
2022
Completed Phase 3
~2690
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
294 Previous Clinical Trials
69,547 Total Patients Enrolled
3 Trials studying Urinary Incontinence
230 Patients Enrolled for Urinary Incontinence
Interdisciplinary research team on neuromuscular diseases (GRIMN)UNKNOWN
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
58 Previous Clinical Trials
31,153 Total Patients Enrolled
2 Trials studying Urinary Incontinence
110 Patients Enrolled for Urinary Incontinence
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the principal goals that this medical study aims to achieve?
"This study aims to assess the compliance level with home exercises over a 12-week treatment period. Additional outcomes of interest include patients' perception of change using the Patients' Global Impression of Improvement (PGI-I) scale, alterations in pelvic floor muscle function measured by dynamometry, and patient-reported estimated improvement through Estimated Percent Improvement (EPI) scale ranging from 0 for no improvement to 100 indicating complete recovery."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger